Question 1

Where is the Brenntag SE stock traded?

Accepted Answer

The Brenntag SE stock trades under the ticker BNR.XETRA on the XETRA exchange. ISIN: DE000A1DAHH0.

Question 2

What does Brenntag SE do?

Accepted Answer

Brenntag SE is a company characterized by the following investment thesis:

Question 3

What are the key metrics for BNR.XETRA?

Accepted Answer

Key metrics for BNR.XETRA include valuation (P/E 24.4, P/S 0.6, P/B 2), profitability (profit margin 2.40%, ROE 8.53%), and growth (revenue —, earnings —). Market capitalization is 8.86B EUR. These metrics give an overview of the company's financial performance and valuation.

Question 4

How has Brenntag SE's stock price performed?

Accepted Answer

Brenntag SE's stock has returned — over 1 year, — over 3 years, and — over 5 years. Performance can vary depending on market conditions and company developments.

Question 5

How is BNR.XETRA valued?

Accepted Answer

BNR.XETRA has the following valuation metrics: P/E Ratio: 24.4, P/S Ratio: 0.6, P/B Ratio: 2. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

Question 6

Does BNR.XETRA pay dividends?

Accepted Answer

Yes, BNR.XETRA pays dividends with a dividend yield of 3.1%. Dividends can be an important component of the total return on an investment.

Question 7

What are the key risks when investing in BNR.XETRA?

Accepted Answer

Key risks for BNR.XETRA include: Brenntag operates as a global chemical distributor across industrial and specialty segments, competing against large, publicly listed full-line distributors, regionally entrenched specialty players, and an array of local and Asia-based competitors. Its direct rivals include global commodity distributors like BASF's distribution operations and Univar Solutions, alongside specialty-focused peers such as IMCD and Azelis. The company faces persistent margin compression from several directions: weakening end-markets, consolidation among suppliers, rising regulatory and ESG compliance expenses, and disruptions stemming from supply-chain fragility and geopolitical instability. In its 2025/2026 disclosures, Brenntag identifies market dynamics, ESG and health & safety obligations, IT infrastructure, and macroeconomic conditions as its most material risk exposures.Weak industrial end-markets combined with pricing pressure are reducing both volumes and gross margins, a dynamic flagged as high and critical market risk in the 2025 annual report [1].Regulatory, environmental, health, and safety compliance costs alongside potential liabilities from handling and storage of hazardous chemicals classified as critical or high risk.Supply-chain and geopolitical disruption—trade barriers, sanctions, input shortages—that interrupt sourcing and increase logistics costs.IT and cybersecurity risks, along with integration challenges tied to enterprise resource planning systems and acquisition consolidation, present material exposure to operational disruption and potential financial loss.Investors should consider these risk factors carefully before making an investment decision.

Question 8

Who are the main competitors of Brenntag SE?

Accepted Answer

Brenntag SE competes with several listed peers in its sector. Brenntag holds the global market leadership position in chemical distribution, operating alongside a small cluster of large, vertically integrated competitors in commodity chemicals and a broader set of specialist distributors focused on specialty ingredients and formulations. The most significant public competitors are Univar Solutions, which operates a large global network with particular strength in North America, and IMCD, which concentrates on specialty chemicals and ingredients with notable formulation and technical service capabilities. Regional and public players including Helm and BASF compete selectively through their own distribution channels and integrated supply operations.

The business faces several material risks. Margin compression emerges from commodity chemical cycles and ongoing supplier consolidation. Regulatory and compliance exposure around hazardous chemical handling represents a persistent operational concern. Acquisition-related integration and execution risk can weigh on performance and capital efficiency. Logistics and supply-chain disruptions pose threats to service reliability and cost structure, with downstream effects on both customer satisfaction and profitability.Univar Solutions Inc. (UNVR.NYSE)IMCD N.V. (IMCD.AS)These competitors influence pricing power, growth opportunities and relative valuation.

	2025	2024	2023	2022	2021
Revenue	15.17B	16.24B	16.82B	19.43B	14.38B
Operating income (EBIT)	733.20M	915.40M	1.12B	1.38B	742.40M
Net income	264.60M	536.20M	714.90M	886.80M	448.30M
Free cash flow	673.70M	564.40M	1.34B	689.50M	189.30M
Total assets	10.84B	11.67B	10.34B	11.37B	10.20B
Equity	4.31B	4.73B	4.30B	4.75B	3.91B
Net debt	2.46B	2.61B	1.82B	1.88B	1.96B

Brenntag SE Financials

Key financial figures

Get More Stock Analyses Like This

Unlock Premium

Full Analysis

Ready for professional stock analysis?

Try for Free

Learn more